NEW YORK, Jan 11 – Third Wave Technologies has signed a development and commercialization agreement with BML, one of the largest clinical reference laboratories in Japan, to use its Invader DNA and RNA mutation detection system for pharmacogenomic and clinical testing, the companies announced Thursday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.